FDA.reportPublic FDA data

HCTZ 800 MG Powder for Oral Suspension [Inzirqo]

RxCUI
2704018
RxNorm name
HCTZ 800 MG Powder for Oral Suspension [Inzirqo]
Display name
HCTZ 800 MG Powder for Oral Suspension [Inzirqo]
Full name
HCTZ 800 MG Powder for Oral Suspension [Inzirqo]
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
INZIRQOHYDROCHLOROTHIAZIDEANI Pharmaceuticals, Inc.41aaea48-6c1b-42c8-a96f-5923d49dc9342025-12-16Warnings, Adverse reactionsExact identifier
rxcui: 2704018

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
41aaea48-6c1b-42c8-a96f-5923d49dc934INZIRQO 800 MG (10 MG/mL) Powder for Oral Suspension [PSN] · hydrochlorothiazide 800 MG Powder for Oral Suspension [Inzirqo] [SBD] · HCTZ 800 MG Powder for Oral Suspension [Inzirqo] [SY] · Inzirqo 800 MG Powder for Oral Suspension [SY]42These highlights do not include all the information needed to use INZIRQO safely and effectively. See full prescribing information for INZIRQO. INZIRQO (hydrochlorothiazide), for oral suspension Initial U.S. Approval: 195920251216